Positive Data IGNITEs TTPH, MDCO Makes A Good TANGO, Wait Continues For EGRX

Today's Daily Dose brings you news about BioTime's progress in dry-AMD trial; Exact Sciences' stellar Q2 results; Incyte's delay in re-submitting Baricitinib NDA; Tetraphase's positive phase III trial results of intravenous Eravacycline in complicated intra-abdominal infections and Neuralstem's disappointing results from major depressive disorder trial.

from RTT - Biotech http://ift.tt/2h1VrqX
via IFTTT